TabletAnti HIV

Sofosbuvir & Ledipasvir Tablets

Sofosbuvir + Ledipasvir · Direct-acting antiviral (NS5B polymerase and NS5A inhibitor)

TabletAnti HIV

Sofosbuvir & Ledipasvir TabletsProspero Healthcare

A fixed-dose tablet combining sofosbuvir, an NS5B polymerase inhibitor, with ledipasvir, an NS5A inhibitor. It is used in the treatment of chronic hepatitis C virus infection.

Uses

Chronic hepatitis C infection

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Sofosbuvir + Ledipasvir
Available strengthsIndicative: 400 mg + 90 mg
Dosage form: Tablet
Therapeutic category: Anti HIV Anti Viral Anti Hepatitis
Therapeutic class: Direct-acting antiviral (NS5B polymerase and NS5A inhibitor)
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category